Hyperbaric Oxygen Therapy in Stroke-Related Sudden Hearing Loss: A Case Report | Canada Hyperbarics Skip to main content
Case Report Undersea Hyperb Med 2026

Hyperbaric Oxygen Therapy in Stroke-Related Sudden Hearing Loss: A Case Report

Kayacık S, Selek F, Aslan A, Karabakan R, Kıratlı Ü — Undersea Hyperb Med, 2026

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers documented the case of a 74-year-old man who developed sudden hearing loss after a stroke and was treated with hyperbaric oxygen therapy.

What They Found

The patient experienced a 70 dB hearing loss in his left ear following a stroke. Initial treatments with intravenous methylprednisolone for ten days and five intratympanic steroid injections did not improve his hearing. However, after 14 sessions of hyperbaric oxygen treatment, his hearing function significantly improved.

Canadian Relevance

No direct Canadian connection identified. Sudden sensorineural hearing loss is not a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

As a single case report, the findings of this study cannot be generalized to a wider patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 41979530
Year Published 2026
Journal Undersea Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Male; Aged; Hearing Loss, Sudden; Stroke; Hearing Loss, Sensorineural; Methylprednisolone; Glucocorticoids; Injection, Intratympanic

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology